0
Skip to Content
RUNX1 Research Program
RUNX1 Research Program
For Patients
For Researchers
For Clinicians
Take Action
About Us
English
DONATE
RUNX1 Research Program
RUNX1 Research Program
For Patients
For Researchers
For Clinicians
Take Action
About Us
English
DONATE
For Patients
For Researchers
For Clinicians
Take Action
About Us
English
Back
DONATE
  • Patient Videos & Webinars,
• 9/16/25

How Does a Genetic Mutation Lead to Cancer

How does a germline genetic mutation (also called a variant) like RUNX1-FPD lead to cancer? What role does a germline v. acquired (also callled somatic) mutation play in the process? Kayla Hamilton, MS, Certified Genetic Counselor, of Boston Children's Hospital and Dana-Farber Cancer Institute explains.

Previous

Hereditary Hematologic Malignancies: Not That Rare - Dr. Courtney DiNardo

Next

Hereditary Hematologic Malignancy Assessment: Making it Mainstream

You Might Also Like

Related Embedded Video Item Thumbnail Module 3: The Potential Promise and Current Challenges of Gene Editing
Related Embedded Video Item Thumbnail RRP Patient Meeting 2023: Upcoming Clinical Studies - Dr. Alan Cantor and Dr. Lea Cunningham
Related Embedded Video Item Thumbnail Dr Blum Health Immune System 2020 RUNX1 Conference
Related Embedded Video Item Thumbnail Mutation-Specific Epigenetic Reprogramming of Hematopoietic Stem Cells in AML
Related Embedded Video Item Thumbnail Part 2: April 2025 Sirolimus Study Update Patient Participants Perspectives and Q&A

Sign Up For Our Email List!

Enter your information below to receive the
latest RUNX1 news and updates!

Stay In Touch

Email RRP

Newsletter

Policies

Privacy Policy

Cookie Policy

Accessibility Statement

Site Resources

News & Updates

Calendar of Events

RRP Blog

DONATE
DONATE
SHOP
SHOP